Teenage boys chasing extra inches are swallowing a cancer drug strong enough to trigger eye damage, bone problems, and dangerous mineral buildups in their blood.
Quick Take
- Doctors warn teens are buying erdafitinib, a prescription bladder cancer drug, hoping it makes them taller.
- The Food and Drug Administration (FDA) label lists serious eye damage and dangerous phosphate spikes as known risks of the drug.
- Some teens online claim they grew two to three inches in two months, but these are unverified personal stories, not medical records.
- No study has tested whether the drug safely or reliably increases height in healthy adolescents.
What Doctors Are Seeing Online Right Now
A trend called “heightmaxxing” has spread across TikTok and other platforms, pushing teen boys toward a drug called erdafitinib. Sold under the brand name Balversa, it treats a specific type of bladder cancer by blocking a protein called FGFR3. That same protein also controls how bones grow, which is why some young men believe it can make them taller.
Reporters have found teens posting videos about taking the drug without a doctor’s involvement. One teen told Rolling Stone he started taking erdafitinib in late August and grew roughly two and a half to three inches in two months, though he was also taking other drugs at the same time. A similar account from a 17-year-old described six to eight centimeters of growth over two months. Neither claim comes with medical records or independent confirmation.
Why the FDA Label Reads Like a Warning Siren
Erdafitinib’s official FDA prescribing information is blunt. It can cause central serous retinopathy, a condition where fluid builds up under the retina and blurs or distorts vision. The label requires patients to get their eyes checked monthly for the first four months of treatment, then regularly after that. If eye damage doesn’t clear up within four weeks, doctors are told to stop the drug for good.
In the clinical trial data the FDA reviewed before approving the drug, nearly 16 percent of patients on the standard dose developed eye problems consistent with this condition. That number comes from cancer patients under close medical supervision, with scheduled eye exams and lab work built into their treatment. Teens buying the drug online get none of that oversight, which makes the real-world risk harder to predict and likely worse.
The Phosphate Problem Nobody Is Talking About
Beyond the eyes, erdafitinib messes with how the body handles phosphate, a mineral that needs to stay in balance for bones and organs to work right. The FDA label says the drug can push phosphate levels too high, which can lead to calcium deposits forming in skin and soft tissue, and in rare cases a painful condition called calciphylaxis. Patients on the drug are supposed to follow a restricted diet and get regular blood tests to catch this early.
None of that monitoring exists for a teenager ordering pills off the internet. A doctor managing a cancer patient can catch warning signs in a blood test and adjust the dose immediately. A teenager hiding pill bottles from his parents has no such safety net, and by the time symptoms show up, the damage may already be done.
Does It Even Work for Height Gain?
Here’s the uncomfortable truth for the kids trying this: nobody has proven it works the way they hope. The FDA’s safety data covers cancer patients, not healthy teenagers with open growth plates. Online commentators point to case reports showing FGFR inhibition can speed up bone growth in children, but those same reports link that growth to skeletal deformities and spinal problems, not clean, proportional height gains.
🚨 TEEN BOYS ARE TAKING CANCER DRUGS TO GET TALLER. WHAT IS HAPPENING?!
A disturbing new social media trend called “Heightmaxxing” has teenage boys turning to black-market cancer medication, hoping to gain a few extra inches.
The drug? Erdafitinib, a prescription medication… pic.twitter.com/ARfOawOoBc
— ℹ️ DeeCoded Feed (@DeetheBee) November 11, 2026
Other voices in the height-optimization space argue the drug can add real centimeters per year in certain clinical settings, but they also admit it only works if growth plates are still open, and that results vary wildly by genetics and hormone timing. That’s a far cry from a guaranteed growth spurt, and it ignores the eye and bone risks sitting right there in the FDA paperwork.
What Parents and Teens Should Actually Weigh
This trend fits an old, troubling pattern. Human growth hormone, anabolic steroids, and research chemicals have all been marketed to teens chasing a better body, usually with thin evidence and real harm. Medical literature has long noted there’s almost no solid data on using these kinds of drugs in healthy adolescents who don’t have a diagnosed medical need. Erdafitinib looks like the latest entry in that same risky cycle, dressed up in new slang.
Common sense says a drug built to fight cancer, with FDA-mandated eye exams and blood tests attached to its own approval, isn’t something a 15-year-old should be ordering through a group chat. Until there’s real research on teens and this drug, the only responsible answer from doctors, and frankly from parents, is a hard no.
Sources:
foxnews.com, accessdata.fda.gov, ndi.fda.moph.go.th, youtube.com, rollingstone.com, wfmd.com, timesofindia.indiatimes.com
